SEC 13F Intelligence

Frazier Management LLC / TREUR

Frazier Management LLC’s Trillium Therapeutics Inc Position

Does Frazier Management LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 3.12M shares worth $55M in Q3 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$55M
Q3 2021
Shares
3.12M
% of Portfolio
+4.40%
Quarters Held
7
position exited

Position History TREUR

Reported value by quarter
Q1 ’20: $10MQ1 ’20Q2 ’20: $22MQ2 ’20Q3 ’20: $40MQ3 ’20Q4 ’20: $45MQ4 ’20Q1 ’21: $33MQ1 ’21Q2 ’21: $30MQ2 ’21Q3 ’21: $55MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20213.12M$55M+4.40%
Q2 20213.12M$30M+2.79%
Q1 20213.12M$33M+2.68%
Q4 20203.05M$45M+3.46%
Q3 20202.79M$40M+3.55%
Q2 20202.75M$22M+1.96%
Q1 20202.44M$10M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of TREUR.